The lupus susceptibility locus sle-2 on mouse chromosome 4 leads to abnormal b-cell development and activation

C. Mohan, L. Morel, B. Croker, E. K. Wakeland

Research output: Contribution to journalArticle

Abstract

Genetic studies have identified Sle-1, Sle-2, and SIe-3 on chromosomes 1,4, and 7, respectively, as lupus susceptibility loci in the NZM2410 murine lupus model. To unravel the pathogenic mechanisms underlying lupus, we are studying C57BL/6 mice made congenic for each of these 3 intervals. B6.NZMc4 mice (congenic for the NZM locus, Sle-2) show aberrant B-cell maturation and activation. One-month-old B6.NZMc4 bone-marrow bear increased percentages of B220"' cells, but significantly reduced mature B-cells (3.3% vs. 7.2%, pO.Ol). Likewise, their spleens have increased B-cells, compared to C57BL/6 (67.3% vs. 54.6%, p<0.001) and CD23low B-cells (22.3% vs. 12.1%, p<0.001) that are CD5-ve, IgD-ve, CD43-ve and J11dhi. B6.NZMc4 B-cells show increased spontaneous, IgM-induced and Ipsinduced proliferation, and an age-dependent increase in splenic IgMproducing B-cells and spontaneous IgM secretion in culture. Finally, B6.NZMc4 mice exhibit increased total serum IgM with polyclonal antigenic reactivity, with the penetrance of this trait increasing from 10% at 5mo age to >90% at 12mo age. In conclusion, Sle-2 impacts B-cell maturation in the marrow, and controls a key event in B-cell activation.

Original languageEnglish (US)
JournalFASEB Journal
Volume10
Issue number6
StatePublished - 1996

Fingerprint

Chromosomes, Human, Pair 4
Chromosomes
B-lymphocytes
B-Lymphocytes
Chemical activation
Cells
chromosomes
loci
mice
cells
Bone Marrow
Congenic Mice
Chromosomes, Human, Pair 7
Chromosomes, Human, Pair 1
Inbred C57BL Mouse
bone marrow
Bone
spleen
Spleen

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

The lupus susceptibility locus sle-2 on mouse chromosome 4 leads to abnormal b-cell development and activation. / Mohan, C.; Morel, L.; Croker, B.; Wakeland, E. K.

In: FASEB Journal, Vol. 10, No. 6, 1996.

Research output: Contribution to journalArticle

@article{3f8db9e1a96d457ba5955a99b355b790,
title = "The lupus susceptibility locus sle-2 on mouse chromosome 4 leads to abnormal b-cell development and activation",
abstract = "Genetic studies have identified Sle-1, Sle-2, and SIe-3 on chromosomes 1,4, and 7, respectively, as lupus susceptibility loci in the NZM2410 murine lupus model. To unravel the pathogenic mechanisms underlying lupus, we are studying C57BL/6 mice made congenic for each of these 3 intervals. B6.NZMc4 mice (congenic for the NZM locus, Sle-2) show aberrant B-cell maturation and activation. One-month-old B6.NZMc4 bone-marrow bear increased percentages of B220{"}' cells, but significantly reduced mature B-cells (3.3{\%} vs. 7.2{\%}, pO.Ol). Likewise, their spleens have increased B-cells, compared to C57BL/6 (67.3{\%} vs. 54.6{\%}, p<0.001) and CD23low B-cells (22.3{\%} vs. 12.1{\%}, p<0.001) that are CD5-ve, IgD-ve, CD43-ve and J11dhi. B6.NZMc4 B-cells show increased spontaneous, IgM-induced and Ipsinduced proliferation, and an age-dependent increase in splenic IgMproducing B-cells and spontaneous IgM secretion in culture. Finally, B6.NZMc4 mice exhibit increased total serum IgM with polyclonal antigenic reactivity, with the penetrance of this trait increasing from 10{\%} at 5mo age to >90{\%} at 12mo age. In conclusion, Sle-2 impacts B-cell maturation in the marrow, and controls a key event in B-cell activation.",
author = "C. Mohan and L. Morel and B. Croker and Wakeland, {E. K.}",
year = "1996",
language = "English (US)",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "6",

}

TY - JOUR

T1 - The lupus susceptibility locus sle-2 on mouse chromosome 4 leads to abnormal b-cell development and activation

AU - Mohan, C.

AU - Morel, L.

AU - Croker, B.

AU - Wakeland, E. K.

PY - 1996

Y1 - 1996

N2 - Genetic studies have identified Sle-1, Sle-2, and SIe-3 on chromosomes 1,4, and 7, respectively, as lupus susceptibility loci in the NZM2410 murine lupus model. To unravel the pathogenic mechanisms underlying lupus, we are studying C57BL/6 mice made congenic for each of these 3 intervals. B6.NZMc4 mice (congenic for the NZM locus, Sle-2) show aberrant B-cell maturation and activation. One-month-old B6.NZMc4 bone-marrow bear increased percentages of B220"' cells, but significantly reduced mature B-cells (3.3% vs. 7.2%, pO.Ol). Likewise, their spleens have increased B-cells, compared to C57BL/6 (67.3% vs. 54.6%, p<0.001) and CD23low B-cells (22.3% vs. 12.1%, p<0.001) that are CD5-ve, IgD-ve, CD43-ve and J11dhi. B6.NZMc4 B-cells show increased spontaneous, IgM-induced and Ipsinduced proliferation, and an age-dependent increase in splenic IgMproducing B-cells and spontaneous IgM secretion in culture. Finally, B6.NZMc4 mice exhibit increased total serum IgM with polyclonal antigenic reactivity, with the penetrance of this trait increasing from 10% at 5mo age to >90% at 12mo age. In conclusion, Sle-2 impacts B-cell maturation in the marrow, and controls a key event in B-cell activation.

AB - Genetic studies have identified Sle-1, Sle-2, and SIe-3 on chromosomes 1,4, and 7, respectively, as lupus susceptibility loci in the NZM2410 murine lupus model. To unravel the pathogenic mechanisms underlying lupus, we are studying C57BL/6 mice made congenic for each of these 3 intervals. B6.NZMc4 mice (congenic for the NZM locus, Sle-2) show aberrant B-cell maturation and activation. One-month-old B6.NZMc4 bone-marrow bear increased percentages of B220"' cells, but significantly reduced mature B-cells (3.3% vs. 7.2%, pO.Ol). Likewise, their spleens have increased B-cells, compared to C57BL/6 (67.3% vs. 54.6%, p<0.001) and CD23low B-cells (22.3% vs. 12.1%, p<0.001) that are CD5-ve, IgD-ve, CD43-ve and J11dhi. B6.NZMc4 B-cells show increased spontaneous, IgM-induced and Ipsinduced proliferation, and an age-dependent increase in splenic IgMproducing B-cells and spontaneous IgM secretion in culture. Finally, B6.NZMc4 mice exhibit increased total serum IgM with polyclonal antigenic reactivity, with the penetrance of this trait increasing from 10% at 5mo age to >90% at 12mo age. In conclusion, Sle-2 impacts B-cell maturation in the marrow, and controls a key event in B-cell activation.

UR - http://www.scopus.com/inward/record.url?scp=33748887078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748887078&partnerID=8YFLogxK

M3 - Article

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 6

ER -